Autoregulation of Polypyrimidine Tract Binding Protein by Alternative Splicing Leading to Nonsense-Mediated Decay

Molecular Cell

Volumn 13, Issue 1, 2004, Pages 91-100

  Wollerton, Matthew C ^a   Gooding, Clare ^a   Wagner, Eric J ^b,c   Garcia Blanco, Mariano A ^b   Smith, Christopher W J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; POLYPYRIMIDINE TRACT BINDING PROTEIN;

ALTERNATIVE RNA SPLICING; ARTICLE; AUTOREGULATION; CONTROLLED STUDY; CYTOPLASM; EXON; HELA CELL; HUMAN; HUMAN CELL; NEGATIVE FEEDBACK; PROTEIN EXPRESSION;

EID: 0346124413     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(03)00502-1     Document Type: Article

References (49)

1. Aparicio S., Chapman J., Stupka E., Putnam N., Chia J.M., Dehal P., Christoffels A., Rash S., Hoon S., Smit A.et al. Whole-genome shotgun assembly and analysis of the genome of Fugu rubripes. Science. 297:2002;1301-1310.
2. Back S.H., Kim Y.K., Kim W.J., Cho S., Oh H.R., Kim J.E., Jang S.K. Translation of polioviral mRNA is inhibited by cleavage of polypyrimidine tract-binding proteins executed by polioviral 3C(pro). J. Virol. 76:2002;2529-2542.
3. Becskei A., Serrano L. Engineering stability in gene networks by autoregulation. Nature. 405:2000;590-593.
4. Bell L.R., Horabin J.I., Schedl P., Cline T.W. Positive autoregulation of sex-lethal by alternative splicing maintains the female determined state in Drosophila. Cell. 65:1991;229-239.
5. Blanchette M., Chabot B. Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization. EMBO J. 18:1999;1939-1952.
6. Charlet B.N., Logan P., Singh G., Cooper T.A. Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing. Mol. Cell. 9:2002;649-658.
7. Ghetti A., Pinol Roma S., Michael W.M., Morandi C., Dreyfuss G. hnRNP I, the polypyrimidine tract-binding protein. distinct nuclear localization and association with hnRNAs Nucleic Acids Res. 20:1992;3671-3678.
8. Gooding C., Kemp P., Smith C.W. A novel polypyrimidine tract binding protein (PTB) paralog expressed in smooth muscle cells. J. Biol. Chem. 278:2003;15201-15207.
9. Goux-Pelletan M., Libri D., d'Aubenton-Carafa Y., Fiszman M., Brody E., Marie J. In vitro splicing of mutually exclusive exons from the chicken β-tropomyosin gene. role of the branch point and very long pyrimidine stretch EMBO J. 9:1990;241-249.
10. Gromak N., Matlin A.J., Cooper T.A., Smith C.W. Antagonistic regulation of alpha-actinin alternative splicing by CELF proteins and polypyrimidine tract binding protein. RNA. 9:2003;443-456.
11. Hamilton B.J., Genin A., Cron R.Q., Rigby W.F.C. Delineation of a novel pathway that regulates CD154 (CD40 ligand) expression. Mol. Cell. Biol. 23:2003;510-525.
12. Helfman D.M., Roscigno R.F., Mulligan G.J., Finn L.A., Weber K.S. Identification of two distinct intron elements involved in alternative splicing of beta-tropomyosin pre-mRNA. Genes Dev. 4:1990;98-110.
13. Hunt S.L., Hsuan J.J., Totty N., Jackson R.J. unr, a cellular cytoplasmic RNA-binding protein with five cold-shock domains, is required for internal initiation of translation of human rhinovirus RNA. Genes Dev. 13:1999;437-448.
14. Huttelmaier S., Illenberger S., Grosheva I., Rudiger M., Singer R.H., Jockusch B.M. Raver1, a dual compartment protein, is a ligand for PTB/hnRNPI and microfilament attachment proteins. J. Cell Biol. 155:2001;775-786.
15. Ishigaki Y., Li X., Serin G., Maquat L.E. Evidence for a pioneer round of mRNA translation. mRNAs subject to nonsense-mediated decay in mammalian cells are bound by CBP80 and CBP20 Cell. 106:2001;607-617.
16. Jumaa H., Nielsen P.J. The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation. EMBO J. 16:1997;5077-5085.
17. Jumaa H., Guenet J.L., Nielsen P.J. Regulated expression and RNA processing of transcripts from the Srp20 splicing factor gene during the cell cycle. Mol. Cell. Biol. 17:1997;3116-3124.
18. Le Guiner C., Lejeune F., Galiana D., Kister L., Breathnach R., Stevenin J., Del Gatto-Konczak F. TIA-1 and TIAR activate splicing of alternative exons with weak 5′ splice sites followed by a U-rich stretch on their own pre-mRNAs. J. Biol. Chem. 276:2001;40638-40646.
19. Le Hir H., Izaurralde E., Maquat L.E., Moore M.J. The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exon-exon junctions. EMBO J. 19:2000;6860-6869.
20. Le Hir H., Gatfield D., Izaurralde E., Moore M.J. The exon-exon junction complex provides a binding platform for factors involved in mRNA export and nonsense-mediated mRNA decay. EMBO J. 20:2001;4987-4997.
21. Lewis B.P., Green R.E., Brenner S.E. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc. Natl. Acad. Sci. USA. 100:2003;189-192.
22. Maniatis T., Tasic B. Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature. 418:2002;236-243.
23. Maquat L.E. Nonsense-mediated mRNA decay. Curr. Biol. 12:2002;R196-R197.
24. Maquat L.E., Carmichael G.G. Quality control of mRNA function. Cell. 104:2001;173-176.
25. Mendell J.T., ap Rhys C.M., Dietz H.C. Separable roles for rent1/hUpf1 in altered splicing and decay of nonsense transcripts. Science. 298:2002;419-422.
26. Mitrovich Q.M., Anderson P. Unproductively spliced ribosomal protein mRNAs are natural targets of mRNA surveillance in C. elegans. Genes Dev. 14:2000;2173-2184.
27. Modrek B., Lee C. A genomic view of alternative splicing. Nat. Genet. 30:2002;13-19.
28. Oh Y.L., Hahm B., Kim Y.K., Lee H.K., Lee J.W., Song O., Tsukiyama Kohara K., Kohara M., Nomoto A., Jang S.K. Determination of functional domains in polypyrimidine-tract-binding protein. Biochem. J. 331:1998;169-175.
29. Okabe M., Ikawa M., Kominami K., Nakanishi T., Nishimune Y. Green mice' as a source of ubiquitous green cells. FEBS Lett. 407:1997;313-319.
30. Pagani F., Buratti E., Stuani C., Bendix R., Dork T., Baralle F.E. A new type of mutation causes a splicing defect in ATM. Nat. Genet. 30:2002;426-429.
31. Patton J.G., Mayer S.A., Tempst P., Nadal Ginard B. Characterization and molecular cloning of polypyrimidine tract-binding protein. a component of a complex necessary for pre-mRNA splicing Genes Dev. 5:1991;1237-1251.
32. Perez I., Lin C.-H., McAfee J.G., Patton J.G. Mutation of PTB binding sites causes misregulation of alternative 3′ splice site selection in vivo. RNA. 3:1997;764-778. a.
33. Perez I., McAfee J.G., Patton J.G. Multiple RRMs contribute to RNA binding specificity and affinity for polypyrimidine tract binding protein. Biochemistry. 36:1997;11881-11890. b.
34. Rahman L., Bliskovski V., Reinhold W., Zajac-Kaye M. Alternative splicing of brain-specific PTB defines a tissue-specific isoform pattern that predicts distinct functional roles. Genomics. 80:2002;245-249.
35. Robberson B.L., Cote G.J., Berget S.M. Exon definition may facilitate splice site selection in RNAs with multiple exons. Mol. Cell. Biol. 10:1990;84-94.
36. Roberts G.C., Smith C.W. Alternative splicing. combinatorial output from the genome Curr. Opin. Chem. Biol. 6:2002;375-383.
37. Rueter S.M., Dawson T.R., Emeson R.B. Regulation of alternative splicing by RNA editing. Nature. 399:1999;75-80.
38. Scadden A.D.J., Smith C.W.J. Interactions between the terminal bases of mammalian introns are retained in inosine-containing pre-mRNAs. EMBO J. 14:1995;3236-3246.
39. Smith C.W.J., Nadal Ginard B. Mutually exclusive splicing of alpha-tropomyosin exons enforced by an unusual lariat branch point location. implications for constitutive splicing Cell. 56:1989;749-758.
40. Southby J., Gooding C., Smith C.W. Polypyrimidine tract binding protein functions as a repressor to regulate alternative splicing of alpha-actinin mutally exclusive exons. Mol. Cell. Biol. 19:1999;2699-2711.
41. Sureau A., Gattoni R., Dooghe Y., Stevenin J., Soret J. SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs. EMBO J. 20:2001;1785-1796.
42. Tateiwa H., Gotoh N., Ichikawa M., Kikuchi T., Yoshimura N. Molecular cloning and characterization of human PTB-like protein. a possible retinal autoantigen of cancer-associated retinopathy J. Neuroimmunol. 120:2001;161-169.
43. Valcarcel J., Gebauer F. Post-transcriptional regulation. the dawn of PTB Curr. Biol. 7:1997;R705-R708.
44. Wagner E.J., Garcia-Blanco M.A. Polypyrimidine tract binding protein antagonizes exon definition. Mol. Cell. Biol. 21:2001;3281-3288.
45. Wagner E.J., Garcia-Blanco M.A. RNAi-mediated PTB depletion leads to enhanced exon definition. Mol. Cell. 10:2002;943-949.
46. Wagner E., Lykke-Andersen J. mRNA surveillance. the perfect persist J. Cell Sci. 115:2002;3033-3038.
47. Wollerton M., Gooding C., Robinson F., Brown E., Jackson R., Smith C. Differential alternative splicing activity of isoforms of polypyrimidine tract binding protein. RNA. 7:2001;819-832.
48. Xie J., Lee J.A., Kress T.L., Mowry K.L., Black D.L. Protein kinase A phosphorylation modulates transport of the polypyrimidine tract-binding protein. Proc. Natl. Acad. Sci. USA. 100:2003;8776-8781.
49. Zachar Z., Chou T.B., Bingham P.M. Evidence that a regulatory gene autoregulates splicing of its transcript. EMBO J. 6:1987;4105-4111.